Skip to main content

Peer Review reports

From: Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

Original Submission
23 May 2007 Submitted Original manuscript
13 Jul 2007 Reviewed Reviewer Report - Daniela Kandioler
15 Jul 2007 Reviewed Reviewer Report - Frederique Penault-Llorca
15 Aug 2007 Author responded Author comments - Yaewon Yang
Resubmission - Version 2
15 Aug 2007 Submitted Manuscript version 2
15 Aug 2007 Author responded Author comments - Yaewon Yang
Resubmission - Version 3
15 Aug 2007 Submitted Manuscript version 3
12 Sep 2007 Reviewed Reviewer Report - Frederique Penault-Llorca
25 Sep 2007 Reviewed Reviewer Report - Daniela Kandioler
25 Oct 2007 Author responded Author comments - Yaewon Yang
Resubmission - Version 4
25 Oct 2007 Submitted Manuscript version 4
Publishing
1 Nov 2007 Editorially accepted
1 Nov 2007 Article published 10.1186/1471-2407-7-203

You can find further information about peer review here.

Back to article page